Cargando…
CFTR trafficking mutations disrupt cotranslational protein folding by targeting biosynthetic intermediates
Protein misfolding causes a wide spectrum of human disease, and therapies that target misfolding are transforming the clinical care of cystic fibrosis. Despite this success, however, very little is known about how disease-causing mutations affect the de novo folding landscape. Here we show that inhe...
Autores principales: | Shishido, Hideki, Yoon, Jae Seok, Yang, Zhongying, Skach, William R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450043/ https://www.ncbi.nlm.nih.gov/pubmed/32848127 http://dx.doi.org/10.1038/s41467-020-18101-8 |
Ejemplares similares
-
Cotranslational Folding Inhibits Translocation from Within the Ribosome–Sec61 Translocon Complex
por: Conti, Brian J., et al.
Publicado: (2014) -
Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR()
por: Bose, Samuel J., et al.
Publicado: (2020) -
Mechanisms of CFTR Folding at the Endoplasmic Reticulum
por: Kim, Soo Jung, et al.
Publicado: (2012) -
Evidence of evolutionary selection for cotranslational folding
por: Jacobs, William M., et al.
Publicado: (2017) -
Cotranslational Folding of Proteins on the Ribosome
por: Liutkute, Marija, et al.
Publicado: (2020)